Burle Venkata Sathya, Panjwani Amelia, Mandalaneni Kesava, Kollu Sunitha, Gorantla Vasavi Rakesh
Anatomical Sciences, St. George's University School of Medicine, Clarksville, USA.
Anatomical Sciences, St. George's University School of Medicine, Whitby, CAN.
Cureus. 2022 Aug 16;14(8):e28068. doi: 10.7759/cureus.28068. eCollection 2022 Aug.
Vertebral artery stenosis (VAS) is the cause of approximately 20% of ischemic strokes in the posterior circulation. There are several causes of vertebral artery stenosis, including atherosclerosis, calcification, dissections, fibromuscular dysplasia, giant cell arteritis, neurofibromatosis type 1, and bony compressions. The most common cause of VAS is atherosclerosis which is derived from the macrophage-induced oxidation of low-density lipoproteins (LDLs), alongside the accumulation of cholesterol. Calcification of the vertebral artery occurs when there is excess calcium and phosphate deposition in the vessel. Dissection of the vertebral artery can lead to the formation of a hematoma causing stenosis of the vertebral artery. Fibromuscular dysplasia can result in stenosis due to the deposition of collagen fibers in the tunica media, intima, or adventitia. Giant cell arteritis, an autoimmune disorder, causes inflammation of the internal elastic membrane resulting in eventual stenosis of the artery. Neurofibromatosis type 1, an autosomal dominant disorder, results in the stenosis of the vertebral artery due to the altered function of neurofibromin. Mechanical compression of the vertebral artery by bone can also cause stenosis of the vertebral artery. Digital subtraction angiography (DSA) is considered the current gold standard in diagnosing vertebral artery stenosis; however, its associated morbidity and mortality have led to increased use of non-invasive techniques such as duplex ultrasonography (DUS), computed tomography angiography (CTA), and magnetic resonance angiography (MRA). Currently, asymptomatic and symptomatic vertebral artery stenoses are treated by risk factor modification and medical treatment. However, it is recommended that surgical (endarterectomy, reconstruction, and decompression) and endovascular (balloon coronary, bare-metal, and drug-eluting stents) treatments are also used for symptomatic vertebral artery stenosis.
椎动脉狭窄(VAS)是后循环缺血性卒中约20%的病因。椎动脉狭窄有多种病因,包括动脉粥样硬化、钙化、夹层、纤维肌发育不良、巨细胞动脉炎、1型神经纤维瘤病和骨质压迫。VAS最常见的病因是动脉粥样硬化,它源于巨噬细胞诱导的低密度脂蛋白(LDL)氧化以及胆固醇积聚。当血管中有过量钙和磷沉积时,椎动脉就会发生钙化。椎动脉夹层可导致血肿形成,引起椎动脉狭窄。纤维肌发育不良可因中膜、内膜或外膜中胶原纤维沉积而导致狭窄。巨细胞动脉炎是一种自身免疫性疾病,可引起内弹性膜炎症,最终导致动脉狭窄。1型神经纤维瘤病是一种常染色体显性疾病,由于神经纤维瘤蛋白功能改变导致椎动脉狭窄。骨质对椎动脉的机械压迫也可导致椎动脉狭窄。数字减影血管造影(DSA)被认为是目前诊断椎动脉狭窄的金标准;然而,其相关的发病率和死亡率导致非侵入性技术如双功超声(DUS)、计算机断层血管造影(CTA)和磁共振血管造影(MRA)的使用增加。目前,无症状和有症状的椎动脉狭窄通过危险因素修正和药物治疗。然而,对于有症状的椎动脉狭窄,也建议采用手术(内膜切除术、重建术和减压术)和血管内(球囊冠状动脉、裸金属和药物洗脱支架)治疗。